This NDC is on FDA's drug shortage list (posted Mar 21, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
CLEOCIN PHOS 300 MG/2 ML VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $1.2242 per ML under NDC 00009305102. Its NADAC has been published 87 times since Nov 20, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
150 mg/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009305102
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
7/23/2025
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA050441FDA Approved
Before 1982
TE Code
AP
On Market Since
11/18/2019
Pharmacological Classes
Price Statistics
The NADAC for CLEOCIN PHOS 300 MG/2 ML VIAL has been published 87 times since Nov 20, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2242 per ML |
|---|---|
| All-time high | $1.2278 (Feb 12, 2025) |
| All-time low | $1.2242 (Feb 19, 2025) |
| 52-week high | $1.2242 |
| 52-week low | $1.2242 |
| Median price | $1.2242 |
| Average price | $1.2248 |
| Largest weekly change | -0.3% (Feb 19, 2025) |
| Weeks tracked | 87 |
| Tracking since | Nov 20, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-0.3%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLEOCIN PHOS 300 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CLEOCIN PHOS 300 MG/2 ML VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $1.2242 per ML (NDC 00009305102), effective Jul 15, 2026.
How has the price of CLEOCIN PHOS 300 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for CLEOCIN PHOS 300 MG/2 ML VIAL has held within roughly two percent of its current level. It has been tracked across 87 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CLEOCIN PHOS 300 MG/2 ML VIAL?
Since Nov 20, 2024, the NADAC for CLEOCIN PHOS 300 MG/2 ML VIAL has ranged from a low of $1.2242 (Feb 19, 2025) to a high of $1.2278 (Feb 12, 2025), with a median of $1.2242 per ML.
Are there cheaper alternatives to CLEOCIN PHOS 300 MG/2 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLEOCIN PHOS 600 MG/4 ML VIAL, is $0.7024 per ML — about 43% below CLEOCIN PHOS 300 MG/2 ML VIAL.
Who manufactures CLEOCIN PHOS 300 MG/2 ML VIAL?
CLEOCIN PHOS 300 MG/2 ML VIAL (NDC 00009305102) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.
Is CLEOCIN PHOS 300 MG/2 ML VIAL in shortage?
Yes — NDC 00009305102 is currently listed in FDA's drug shortage database (posted Mar 21, 2023). Reported reason: Discontinuation of the manufacture of the drug.